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Abstract
In response to our article, Davidson and Dahl offer commentary and advice regarding additional
topics crucial to a comprehensive prescriptive agenda for future research on mindfulness and
meditation. Their commentary raises further challenges and provides an important complement to
our article. More consideration of these issues is especially welcome because limited space
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precluded us from addressing all relevant topics. While we agree with many of Davidson and
Dahl’s suggestions, the present reply (a) highlights reasons why the concerns we expressed are
still especially germane to mindfulness and meditation research (even though those concerns may
not be entirely unique) and (b) gives more context to other issues posed by them. We discuss
special characteristics of individuals who participate in mindfulness and meditation research and
focus on the vulnerability of this field inherent in its relative youthfulness compared to other more
mature scientific disciplines. Moreover, our reply highlights the serious consequences of adverse
experiences suffered by a significant subset of individuals during mindfulness and other
contemplative practices. We also scrutinize common contemporary applications of mindfulness
and meditation to illness, and some caveats are introduced regarding mobile technologies for
guidance of contemplative practices.
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In their five-point commentary in this issue, Davidson and Dahl (2018) raise additional
challenges for contemporary research on mindfulness and meditation that complement our
original article (Van Dam et al., 2018). While we basically agree with them, the subsequent
sections of this reply (a) highlight major reasons why our previous concerns remain
especially relevant despite their first point and (b) provide further provisos regarding their
second through fifth points.

Nascent Scientific Fields Are Especially Susceptible to Methodological
Author Manuscript

Issues
We agree that many methodological issues and pitfalls emphasized in our article are not
limited to research on mindfulness and meditation. As pointed out, similar problems are also
endemic to psychological science and neuroscience more generally (cf. Open Science
Collaboration, 2015). Nevertheless, the practice and investigation of mindfulness and
meditation remain especially fraught because of at least three specific contextual factors,
which considerably increase the seriousness of the particular concerns that we previously
raised.
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The first factor involves the types of individual who participate in research on mindfulness
and meditation practices. As we acknowledged in our original article, individual
physiological differences can present challenges to neuroimaging studies generally. Yet
these specific challenges may become systematic confounds in mindfulness and meditation
research participants. For example, respiratory artifacts are likely more extreme in
participants highly prone to focus on and manipulate their breath during meditative and/or
nonmeditative rest states. Tendencies toward lower respiratory rates in meditators relative to
control groups would present a confound in statistical analyses and interpretations of brain
images that compare them. Furthermore, individuals who seek complementary and/or
integrative treatments for various medical conditions may differ in important ways from
those who seek traditional medical treatments (e.g., Honda & Jacobson, 2005).
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The second factor pertains to the youth of mindfulness and meditation research. Domains of
scientific research that have been under way for centuries (e.g., physics, chemistry, and
biology) are less likely to have their trajectories misdirected by a few flashy findings. In
contrast, relatively younger fields may be undermined when the reliability and
reproducibility of empirical results based on exciting preliminary findings are subsequently
ascertained to be questionable (e.g., Open Science Collaboration, 2015). Technical research
on mindfulness and meditation is still in its infancy compared to psychological science more
generally. Mindfulness and meditation research really began only in the 1970s, though it has
already suffered one major setback through questionable research practices and unverifiable
claims espoused by the transcendental meditation movement (Skolnick, 1991).
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The third factor is that, unlike research in many other areas of psychological science, studies
of mindfulness and meditation can occasionally be related to serious negative side effects.
Because of this nascent subfield’s relatively higher riskiness, extreme youthfulness, and past
encounter with one near-miss “extinction” event, its prevailing methodological weaknesses
and other improprieties should be resolved as soon as possible. Otherwise, funding agencies,
scientists at large, and the public may soon choose to withdraw support from such research
as a whole.

Caveat Emptor: Meditation Can Cause Adverse Side Effects Wherein Small
Subsets of Participants Matter a Lot

Author Manuscript

According to Davidson and Dahl (2018), it will be especially fruitful for future research to
investigate additional types of meditation beyond the popular (e.g., mindfulness). We agree
provisionally with this intriguing aspect of their expanded research agenda. Some crucial
caveats, nonetheless, must continue to be kept in mind. Specifically, all new investigations of
contemplative practices should pose minimal risk and offer well-justified potential for
human benefit before being undertaken.
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Our reasons for emphasizing this important concern stem from compelling evidence that
injudicious participation in mindfulness-based interventions (MBIs) and other types of
meditation can, and sometimes does, cause (or exacerbate) serious negative experiences (cf.
Lindahl et al., 2017). At a minimum, it is plausible that such adverse effects occur at rates
approximately equal to what happens generally in psychotherapy (i.e., approximately 5%;
Crawford et al., 2016). Research on meditation-related adversities in 60 Buddhist meditation
practitioners revealed that serious negative side effects occurred for 12% of the sample
within 10 days after initiating practice, 25% of participants encountered adversities while
practicing less than an hour per day, and 30% had adverse experiences in daily practice
(Lindahl, Fisher, Cooper, Rosen, & Britton, 2017). These findings suggest that simple
practice, not just intensive retreats (though the latter are more commonly associated with
adverse outcomes), may result in adverse experiences.
Even if the adverse event rate for practitioners were only 5%, it would nonetheless be far
from nontrivial in absolute terms. Nearly 18 million adults in the United States practice
meditation annually (Clark, Black, Stussman, Barnes, & Nahin, 2015). So meditation-related
negative side effects may occur in almost 1 million U.S. adults per year. Moreover, as
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highlighted by news media and case reports (Kuijpers, van der Heijden, Tuinier, &
Verhoeven, 2007; Vendel, 2017), some such effects (e.g., psychosis and suicide) are so
severe that even very low frequencies of occurrence would not fully assuage our concerns.

Attention to Medical MBIs Remains Important and Future Studies of
Meditation for Enhanced “Well-Being” May Be Misguided

Author Manuscript

A related corollary point made by Davidson and Dahl is that our original article concentrated
quite heavily on the use of mindfulness practice for treating illness and diseases. As they
note, this usage is very recent: a late 20th- and early 21st-century development. However,
mindfulness meditation and other contemplative practices were developed initially many
centuries ago “primarily to actualize human flourishing.” Their commentary therefore
advocates that future research should focus more on how various contemplative practices
“can be used to improve well-being in ‘healthy’ individuals.”
Of course, we agree, prima facie, that the contemporary use of mindfulness practice in
medical contexts is a recent development. Yet our agreement with this point should not be
taken as a license from us for turning attention away from medical-based studies of
mindfulness and exclusively toward studies of well-being enhancement through meditation.
Rather, there are strong reasons for continuing to focus attention on medical MBIs and for
maintaining some skepticism about prospective meditation-based improvements of healthy
individuals’ well-being.
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The grounds for continued attention to MBIs in medical contexts have several firm bases.
For example, according to a recent Scopus search, 60% of past studies on mindfulness
appeared in medical and/or health journals, with 30% of them (80% for psychology articles)
mentioning the term clinical in their abstracts, keywords, or titles. This manifest popularity,
qualified by serious concerns raised in our original article (Van Dam et al., 2018), well
warrants conducting additional future MBIs for treating mental and physical illness.
Moreover, even if mindfulness and other contemplative practices become prominent ways to
enhance “well-being” and actualize “flourishing” in “otherwise healthy individuals,” doing
so will still require helping unhealthy individuals to overcome their afflictions before
pursuing these higher-level goals (Maslow, 1943).
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Even if researchers could achieve valid psychological measurement of “well-being” and
“flourishing” (concepts that experience similar measurement difficulties to mindfulness), the
contemplative practices chosen for study may not be especially well suited to attaining
contemporary versions of these particular higher-level goals. Historically, many such
practices arose in religious and spiritual contexts where the motivations and goals for what
could and would be achieved through meditation differed greatly from secular Western
notions of health, well-being, and flourishing (McMahan, 2008; Sharf, 2015). Thus, given
such qualifications, it is currently less than obvious that successful future research on uses of
meditation for enhancement of human well-being and flourishing can be properly or easily
accomplished.
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Optimal Dose-Response Curves Depend on Desired Outcomes
Davidson and Dahl (2018) also raise basic issues about what are the optimal duration,
intensity, frequency, and temporal spacing (i.e., dosage script) for mindfulness and other
contemplative practices. As they correctly note, resolving these issues may depend on how
moments of meditation are coordinated with other activities of daily living. Other crucial
considerations must be added to this mix.
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While ascertaining appropriate “dosages” of contemplative practice is necessary to optimize
mindfulness and meditation, doing so cannot happen without specifying what would be the
desired outcome of the practice. Is it alleviating particular disease symptoms, becoming a
more effective soldier, increasing a targeted metric of “well-being,” attaining enlightenment,
or some alternative objective? After we have the answer, and sufficient information has been
obtained about potential negative side effects (cf. Lindahl et al., 2017), then and only then
we can proceed to formulate an optimal practice regimen that maximizes benefits and
minimizes adverse experiences (Hansen, Lambert, & Forman, 2002; Muller & Milton,
2012). Most likely, the optimal “dosage script” for meditation to alleviate moderate anxiety
will differ considerably from that needed to attain general well-being. Also, the doseresponse curves are likely nonlinear, and their ideal parameters will vary within and across
different populations.

Mobile Platforms for Mindfulness and Meditation Should Be Properly
Validated
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Finally, Davidson and Dahl (2018) tout mobile technologies for implementing and
evaluating contemplative practices. Indeed, such may have some promise (cf. Clough &
Casey, 2015). Yet recent evaluations of current analogous technology for treating depression
(Huguet et al., 2016) and anxiety (Sucala et al. 2017) have revealed multiple unresolved
problems. Among them are insufficient development data from appropriate potential users,
and infidelity of implemented objectives (e.g., apps that poorly implement practices that they
are supposed to facilitate).
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Similar challenges may continue to prevail for mindfulness and meditation apps, of which
there were more than 500 in 2015 (Mani, Kavanagh, Hides, & Stoyanov, 2015). Only about
5% of them actually provided mindfulness education and training per se. Regardless, many
such mobile technologies still do not adequately accommodate individual differences in
motivation and trajectories of skill acquisition, a problematic gap that has likewise plagued
manuals for implementing evidence-based psychotherapies (cf. Chorpita, 2002). Thus,
before mindfulness and meditation come to use mobile technology as their preferred default
support system, much more work will be needed to ensure fidelity of delivery and
effectiveness compared with face-to-face guidance.
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